Literature DB >> 10103025

Tissue expression and amino acid sequence of murine UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase.

R Horstkorte1, S Nöhring, N Wiechens, M Schwarzkopf, K Danker, W Reutter, L Lucka.   

Abstract

Neuraminic acids are widely expressed as terminal carbohydrates on glycoconjugates and are involved in a variety of biological functions. The key enzyme of N-acetylneuraminic acid synthesis is UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase, which catalyses the first two steps of neuraminic acid biosynthesis in the cytosol. In this study we report the complete amino acid sequence of the mouse UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase. The ORF of 2166 bp encodes 722 amino acids and a protein with a predicted molecular mass of 79.2 kDa. Northern blot analysis and in situ hybridization revealed that UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase is expressed at early stages during development and in all tissues investigated with a maximal expression in the liver.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103025     DOI: 10.1046/j.1432-1327.1999.00253.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Sialylation is essential for early development in mice.

Authors:  Martina Schwarzkopf; Klaus-Peter Knobeloch; Elvira Rohde; Stephan Hinderlich; Nicola Wiechens; Lothar Lucka; Ivan Horak; Werner Reutter; Rüdiger Horstkorte
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

2.  Domain-specific characteristics of the bifunctional key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.

Authors:  Astrid Blume; Wenke Weidemann; Ulrich Stelzl; Erich E Wanker; Lothar Lucka; Peter Donner; Werner Reutter; Rüdiger Horstkorte; Stephan Hinderlich
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

3.  Genetics of GNE myopathy in the non-Jewish Persian population.

Authors:  Alireza Haghighi; Shahriar Nafissi; Abrar Qurashi; Zheng Tan; Hosein Shamshiri; Yalda Nilipour; Amirreza Haghighi; Robert J Desnick; Ruth Kornreich
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

4.  Reduced sialylation status in UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE)-deficient mice.

Authors:  Daniel Gagiannis; André Orthmann; Ilona Danssmann; Martina Schwarzkopf; Wenke Weidemann; Rüdiger Horstkorte
Journal:  Glycoconj J       Date:  2007-01-19       Impact factor: 2.916

5.  Tissue specific expression of sialic acid metabolic pathway: role in GNE myopathy.

Authors:  Kapila Awasthi; Alok Srivastava; Sudha Bhattacharya; Alok Bhattacharya
Journal:  J Muscle Res Cell Motil       Date:  2020-10-07       Impact factor: 2.698

Review 6.  UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.

Authors:  Stephan Hinderlich; Wenke Weidemann; Tal Yardeni; Rüdiger Horstkorte; Marjan Huizing
Journal:  Top Curr Chem       Date:  2015

7.  Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis.

Authors:  Alexandra Castilho; Martin Pabst; Renaud Leonard; Christiane Veit; Friedrich Altmann; Lukas Mach; Josef Glössl; Richard Strasser; Herta Steinkellner
Journal:  Plant Physiol       Date:  2008-03-07       Impact factor: 8.340

Review 8.  Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle.

Authors:  A Broccolini; T Gidaro; R Morosetti; C Sancricca; M Mirabella
Journal:  Acta Myol       Date:  2011-10

9.  Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.

Authors:  Anagha P Phadke; Chris Jay; Salina J Chen; Courtney Haddock; Zhaohui Wang; Yang Yu; Derek Nemunaitis; Gregory Nemunaitis; Nancy S Templeton; Neil Senzer; Phillip B Maples; Alex W Tong; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-05-08

10.  Sialic acid utilisation and synthesis in the neonatal rat revisited.

Authors:  Peter I Duncan; Frédéric Raymond; Andreas Fuerholz; Norbert Sprenger
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.